These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1186 related items for PubMed ID: 19780039

  • 1. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K, Ström A, Lock JG, Gustafsson JA, Haldosén LA, Helguero LA.
    J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
    [Abstract] [Full Text] [Related]

  • 2. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 3. Influence of exogenous tissue factor on estrogen receptor alpha expression in breast cancer cells: involvement of beta1-integrin, PAR2, and mitogen-activated protein kinase activation.
    Collier ME, Li C, Ettelaie C.
    Mol Cancer Res; 2008 Dec; 6(12):1807-18. PubMed ID: 19074826
    [Abstract] [Full Text] [Related]

  • 4. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 5. Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.
    Zhao C, Lam EW, Sunters A, Enmark E, De Bella MT, Coombes RC, Gustafsson JA, Dahlman-Wright K.
    Oncogene; 2003 Oct 23; 22(48):7600-6. PubMed ID: 14576822
    [Abstract] [Full Text] [Related]

  • 6. A laminin-rich basement membrane matrix influences estrogen receptor beta expression and morphology of MDA-MB-231 breast cancer cells.
    Neubauer H, Ruoff A, Paessler N, Solomayer E, Wallwiener D, Fehm T.
    Oncol Rep; 2009 Feb 23; 21(2):475-81. PubMed ID: 19148525
    [Abstract] [Full Text] [Related]

  • 7. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
    Jarzabek K, Koda M, Kozlowski L, Mittre H, Sulkowski S, Kottler ML, Wolczynski S.
    Eur J Cancer; 2005 Dec 23; 41(18):2924-34. PubMed ID: 16289616
    [Abstract] [Full Text] [Related]

  • 8. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 9. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH.
    Mol Cancer Res; 2004 Sep 15; 2(9):523-31. PubMed ID: 15383631
    [Abstract] [Full Text] [Related]

  • 10. Ligand-induced regulation of ERalpha and ERbeta is indicative of human breast cancer cell proliferation.
    Power KA, Thompson LU.
    Breast Cancer Res Treat; 2003 Oct 15; 81(3):209-21. PubMed ID: 14620916
    [Abstract] [Full Text] [Related]

  • 11. Integrin expression on normal and neoplastic human breast epithelium.
    Damjanovich L, Fülöp B, Adány R, Nemes Z.
    Acta Chir Hung; 1997 Oct 15; 36(1-4):69-71. PubMed ID: 9408292
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer.
    Lin CY, Ström A, Li Kong S, Kietz S, Thomsen JS, Tee JB, Vega VB, Miller LD, Smeds J, Bergh J, Gustafsson JA, Liu ET.
    Breast Cancer Res; 2007 Oct 15; 9(2):R25. PubMed ID: 17428314
    [Abstract] [Full Text] [Related]

  • 13. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
    Park BW, Kim KS, Heo MK, Yang WI, Kim SI, Kim JH, Kim GE, Lee KS.
    J Surg Oncol; 2006 May 01; 93(6):504-10. PubMed ID: 16615154
    [Abstract] [Full Text] [Related]

  • 14. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R.
    J Mol Endocrinol; 2005 Apr 01; 34(2):553-66. PubMed ID: 15821116
    [Abstract] [Full Text] [Related]

  • 15. alpha1,3 fucosyltransferase-VII up-regulates the mRNA of alpha5 integrin and its biological function.
    Wang QY, Zhang Y, Shen ZH, Chen HL.
    J Cell Biochem; 2008 Aug 15; 104(6):2078-90. PubMed ID: 18452157
    [Abstract] [Full Text] [Related]

  • 16. 17β-estradiol enhances α(5) integrin subunit gene expression through ERα-Sp1 interaction and reduces cell motility and invasion of ERα-positive breast cancer cells.
    Sisci D, Middea E, Morelli C, Lanzino M, Aquila S, Rizza P, Catalano S, Casaburi I, Maggiolini M, Andò S.
    Breast Cancer Res Treat; 2010 Nov 15; 124(1):63-77. PubMed ID: 20052536
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO, Collett K, Tretli S, Akslen LA, Grotmol T.
    APMIS; 2009 Sep 15; 117(9):644-50. PubMed ID: 19703124
    [Abstract] [Full Text] [Related]

  • 18. Effects of exon-deleted estrogen receptor beta transcript variants on growth, apoptosis and gene expression of human breast cancer cell lines.
    Treeck O, Juhasz-Boess I, Lattrich C, Horn F, Goerse R, Ortmann O.
    Breast Cancer Res Treat; 2008 Aug 15; 110(3):507-20. PubMed ID: 17876701
    [Abstract] [Full Text] [Related]

  • 19. Detection of an elevated HER2 expression in MCF-7 breast cancer cells overexpressing estrogen receptor beta1.
    Lattrich C, Juhasz-Boess I, Ortmann O, Treeck O.
    Oncol Rep; 2008 Mar 15; 19(3):811-7. PubMed ID: 18288420
    [Abstract] [Full Text] [Related]

  • 20. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC.
    Cancer Res; 2005 Apr 15; 65(8):3487-92. PubMed ID: 15833885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 60.